Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC)
Sukeshi Patel Arora, Laura Tenner, John Sarantopoulos, Jay Morris, Qianqian Liu, Jenny Mendez, Tyler J. Curiel, Joel Michalek, Devalingam Mahalingam
Topics & Concepts
MedicineRegorafenibHydroxychloroquineColorectal cancerInternal medicineVorinostatOncologyAfliberceptAdverse effectBevacizumabClinical endpointCancerChemotherapyClinical trialHistone deacetylaseBiologyBiochemistryHistoneCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)GeneDiseaseAutophagy in Disease and TherapyHistone Deacetylase Inhibitors ResearchColorectal Cancer Treatments and Studies